Ultra Medica Pharmaceutical Industries / Products

Ultra Medica Pharmaceutical Industries







Products » » Musculoskeletal Drugs

Product Search

Drug Index A to Z

All 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Orphipal ( Aspirin + Orphenadrine Citrate + Caffeine )

  • Effective Material
    Aspirin 385 mg + Orphenadrine Citrate 25 mg + Caffeine 30 mg
  • Caliber
    385 mg + 25 mg + 30 mg
  • Pharmacologic Form
    - Stimulants
    - Muscarinic antagonist
  • Therapeutic Categories
    Musculoskeletal Drugs
  • Pharmaceutical Form
Each 1 tablet contains :
385 mg Aspirin
25 mg Orphenadrine Citrate
30 mg Caffeine
Side effect
It may be happen in few cases tachycardia , palpitation , urinary hesitancy or retention , dry mouth, blurred vision , dilatation of the pupil , weakness , nausea headache , dizziness , constipation , drowsiness .
Pharmacodynamics properties
This product contains Orphenadrine citrate which is centrally acting muscle relaxant , his mode of therapeutic action may be related to its analgesic properties and also possesses anticholinergic action , Aspirin which has analgesic and antipyretic action and Caffeine which enhance the analgesic effect to this product .
Therapeutic indications
This product is indicated to :
1- Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders ( low back pain , neck pain . muscle injuries , muscle spasm ).
2- 2The Orphenadrine component is indicated as an adjunct to rest , physical therapy and other measures for the relief of discomfort associated with acute painful musculoskeletal condition .
This product should not be used in patients with glaucoma , pyloric and duodenal obstruction ,achalsia , prostatichypertrophy or obstruction at the bladder neck , myasthenia gravis , patients know to be sensitive to aspirin or caffeine .
Warnings and precautions
Caution should be taken when used this product in patients with chicken pox influenza or flu symptoms , because risk of occurring Reye's syndrome , and while operating machinery or driving a motor vehicle , and in patient , with the presence of peptic ulcers and coagulation abnormalities .
Pregnancy and lactation
Safety of the use of this preparation in pregnancy and during lactation has not been established .
Use of the drug in such patients requires that the potential benefits of the drug be weighed against its possible hazard to the mother and child.
As doctor prescribe and it is recommended as : 1 → 2 tablets 3 → 4 times daily .
Box of 20 tablets

Advertising posters of the product